Updated:
Mendham Investment Group
Mendham Investment Group is a US-based investment company headquartered in Mendham. It employs a Venture Capital strategy. The firm has one staff member, one...
Mendham Investment Group
Mendham Investment Group is a US-based investment company headquartered in Mendham. It employs a Venture Capital strategy. The firm has one staff member, one of whom is an investment professional.
General information
Firm type
Generalist
Year founded
2011
Location
Region
North America
Country
United States
City
Mendham
Corporate office
Mendham, NJ, United States
Principals
Sol J. Barer
Founder
Ido Zairi
Co-founder and Managing Director
Michael Ingber
Lead
Sector focus
Frequently asked questions
Who runs investment decisions at Mendham Investment Group?
Dr. Michael Ingber leads the firm's investment operations alongside co-founder and Managing Director Ido Zairi. Ingber is also a practicing urologist and director at Garden State Urology, which grounds the firm's investment process in clinical experience. Sol J. Barer, founder and former Celgene CEO, provides the strategic direction and scientific network that drive the group's deal-sourcing capability.
Where does Mendham Investment Group's capital come from?
The firm deploys the personal capital of Sol J. Barer, who built his wealth over decades as CEO and later Chairman of Celgene. The biotechnology company's $74 billion acquisition by Bristol Myers Squibb in 2019 was a significant liquidity event. Mendham Investment Group does not raise outside funds or operate as a pooled investment vehicle.
How does Mendham Investment Group source its investments?
Sourcing leans heavily on the principals' personal networks in biotechnology and clinical medicine. Sol Barer's standing in the life sciences community—he designed a leadership program for the Israeli 8400 Network of health-tech executives—opens doors to entrepreneurs and scientific founders. Dr. Ingber's urology practice provides a direct conduit to early-stage medical device companies and physician-driven innovations.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: